pentadecapeptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-17. Numbers and descriptions here follow the published literature rather than marketing material.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | Linear, fifteen residues |
| Sequence | GEPPPGKPADDAGLV | Single-letter amino acid code |
| Approximate mass | 1419 Da | Value reported for the free peptide |
| Reported origin | Fragment of a gastric juice protein | Used as the design template |
| Common synonyms | Body protection compound 157; PL 14736 | Naming varies across papers and suppliers |
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
In the present day, Quechuas continue to be victims of political conflicts and ethnic persecution. In the internal conflict in Peru in the 1980s between the government and Sendero Luminoso about three-quarters of the estimated 70,000 death toll were Quechuas, whereas the war parties were without exception whites and mestizos (people with mixed descent from both Natives and Spaniards).
=== Time capsule === A time capsule was buried in the Sir Frederick Banting Square in 1991 to honour the 100th anniversary of Sir Frederick Banting's birth. It was buried by the International Diabetes Federation youth representatives and Governor General of Canada Ray Hnatyshyn. It will be exhumed if a cure for diabetes is found.
=== Pain and pain management === Most patients report mild to moderate pain during insertion, and a minority report severe pain. Clinicians tend to underestimate this pain. In a study of 200 insertions, patients rated their peak pain at a mean of 65 on a 100-point scale, while providers rated it at 35. Guidelines historically did not recommend routine pain relief, and patients sharing their experiences on social media in the 2020s increased scrutiny of the practice. In 2025 the American College of Obstetricians and Gynecologists (ACOG) acknowledged that many patients feel clinicians have dismissed their pain. Options include NSAIDs, topical lidocaine, a paracervical block, nitrous oxide, inhaled methoxyflurane (the "green whistle"), and intravenous sedation or general anaesthesia where available. Sedation and general anaesthesia usually require a referral or separate appointment. Some clinics also offer virtual reality headsets for distraction. Evidence for individual methods is mixed. A Cochrane review found that lidocaine gel and most NSAIDs did not reduce pain, while some lidocaine formulations, tramadol and naproxen helped in some groups. A 2026 meta-analysis found no significant effect of virtual reality on pain. Paracervical block is underused in the United States. The US CDC and ACOG recommend that clinicians discuss expected pain and pain relief options with every patient before insertion.
The transition from capitalism to socialism was signified by the introduction of the first five-year plan and the 1936 Soviet Constitution. By the late 1920s, Stalin established ideological orthodoxy in the CPSU, Soviet Union, and Communist International to establish universal Marxist–Leninist praxis. The formulation of the Soviet version of dialectical and historical materialism by Stalin and his associates, such as in Stalin's text Dialectical and Historical Materialism, became the official Soviet interpretation of Marxism, and was taken as example by Marxist–Leninists in other countries. This text became the foundation philosophy of Marxism–Leninism. In 1938, Stalin's textbook History of the Communist Party of the Soviet Union (Bolsheviks) popularised Marxism–Leninism. The internationalism of Marxism–Leninism was expressed in supporting revolutions in other countries, initially through the Communist International, then through the concepts of national democratic states and states of socialist orientation after de-Stalinisation. The establishment of other communist states after World War II resulted in Sovietisation, and these states tended to follow the Marxist–Leninist model of five-year plans and rapid industrialisation, political centralisation, and repression. During the Cold War, Marxist–Leninist countries like the Soviet Union were a major force in international relations.
Sources: en.wikipedia.org
Currently, very few methods are used to synthesize (S)-dapoxetine. This novel approach consists of only six steps in which three main steps are shown above. The initial reactant is trans-cinnamyl alcohol, which is commercially available. Sharpless asymmetric epoxidation and Mitsunobu reaction have been used to produce expected (S)-dapoxetine. The overall yield is 35%. This method is considered a good choice compared to the known methods due to high yield and easily obtainable reactants.
=== 1971 === January 25: Idi Amin launches a successful coup d'état against Milton Obote in Uganda and declares himself President of Uganda. Under Amin, Uganda would switch allegiances to the Eastern Bloc and develop strong ties to the Soviet Union and East Germany. February 8: South Vietnamese forces enter Laos to briefly cut the Ho Chi Minh Trail. February 11: Seabed Arms Control Treaty is signed banning the placement of nuclear weapons outside of a country's 12-mile (22.2 km) coastal zone. March 10: Dominion of Ceylon declared under emergency conditions after communist People's Liberation Front attacks the American embassy. March 25 : Bangladeshi genocide From The West Pakistani Troops until 16 December March 26: Bangladeshi Declaration of Independence and Bangladesh Liberation War begin April 19: Salyut 1 is launched becoming the first space station. May 15: Anwar Sadat's Corrective Revolution purges Nasserist members of the government and security forces, and eventually expels the Soviet military from Egypt. May 28: Mars 3 is launched. May 30: Mariner 9 is launched. July 19–22: a communist-backed coup attempted unsuccessfully against Jaafar Nimeiry in Sudan. September: 105 Soviet officials expelled from Great Britain by Prime Minister Edward Heath in Operation FOOT. September 3: Four-Power Agreement on Berlin is signed by the United Kingdom, the Soviet Union, France, and the United States. October 11: Salyut 1 burns up in the atmosphere.
Wright Museum of African American History, and several other institutions—by constructing a public space that creates a sense of inclusion and harmony with the rest of the city. Public transportation within the Downtown area has also been a target for private investors, as evidenced by Quicken Loans' investment in Detroit's QLine railcar, which currently runs a 3.3 miles (5.3 km) track along Woodward Avenue. Gilbert's investment within the city is not limited to real estate; he has also assembled a security force that patrols the downtown area and monitors hundreds of security centers attached to buildings operated by his own Rock Ventures. These agents have eyes on almost every corner of downtown Detroit and coordinate public safety and monitor legal infractions in partnership with Wayne State University's private police agency and Detroit's own police force. In addition to these efforts to revitalize Detroit's social atmosphere, Gilbert and Quicken Loans have cultivated a strong and diverse workforce within Detroit by incentivizing employees to live in Midtown and offering subsidies and loans. Through such initiatives, Gilbert has focused on "creating opportunity" for Detroiters and encouraged reinvestment within the city's economy. However, the approach many of these private investors have taken within the downtown area has been criticized. Many have argued that the influx of private capital into Downtown Detroit has resulted in dramatic changes to the social and socio-economic character of the city.
The internal examination evaluates the condition of the nasal septum, the internal and external nasal valves, the turbinates, and the nasal lining, paying special attention to the structure and the form of the nasal dorsum and the tip of the nose. Furthermore, when warranted, specific tests—the mirror test, vasoconstriction examinations, and the Cottle maneuver—are included to the pre-operative evaluation of the prospective rhinoplasty patient. Established by Maurice H. Cottle (1898–1981), the Cottle maneuver is a principal diagnostic technique for detecting an internal nasal-valve disorder; whilst the patient gently inspires, the surgeon laterally pulls the patient's cheek, thereby simulating the widening of the cross-sectional area of the corresponding internal nasal valve. If the maneuver notably facilitates the patient's inspiration, that result is a positive Cottle sign—which generally indicates an airflow-correction to be surgically effected with an installed spreader-graft. Said correction will improve the internal angle of the nasal valve and thus allow unobstructed breathing. Nonetheless, the Cottle maneuver occasionally yields a false-positive Cottle sign, usually observed in the patient affected by alar collapse, and in the patient with a scarred nasal-valve region.
ATP + β-D-ribosylnicotinate = ADP + nicotinate β-D-ribonucleotide In particular, it converts nicotinamide riboside into nicotinamide mononucleotide (NMN) and nicotinic acid riboside into nicotinic acid mononucleotide (NaMN). This reaction is part of one of the pathways of producing NAD+, but NMN can also be directly produced from nicotinamide through the action of the enzyme nicotinamide phosphoribosyltransferase (see Nicotinamide adenine dinucleotide § Biosynthesis for more details).
Sources: en.wikipedia.org
It is a synthetic fifteen-amino-acid peptide whose sequence matches part of a protein found in human gastric juice. It is made by chemical synthesis, not purified from tissue. The name derives from an early fragment label, not from a molecular weight.
The sequence corresponds to a segment of a naturally occurring gastric protein, so related sequence material exists in the body. The peptide itself as sold and studied is a laboratory-synthesized product. Whether an identical free peptide circulates naturally is not established.
No major regulatory agency has approved it as a medicine for any indication. It appears in research supply channels and, in some jurisdictions, in compounded preparations. Clinical use therefore sits outside standard approved-product pathways, and regulatory status varies by country.
It does not occur in the form that is supplied commercially. Its sequence matches a fragment of a larger gastric protein, and the research material is produced synthetically in a laboratory. The fragment described in the early literature is generally the same synthetic pentadecapeptide.